1. Home
  2. TBPH vs CCNE Comparison

TBPH vs CCNE Comparison

Compare TBPH & CCNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • CCNE
  • Stock Information
  • Founded
  • TBPH 2013
  • CCNE 1865
  • Country
  • TBPH United States
  • CCNE United States
  • Employees
  • TBPH N/A
  • CCNE N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • CCNE Major Banks
  • Sector
  • TBPH Health Care
  • CCNE Finance
  • Exchange
  • TBPH Nasdaq
  • CCNE Nasdaq
  • Market Cap
  • TBPH 699.0M
  • CCNE 775.5M
  • IPO Year
  • TBPH N/A
  • CCNE N/A
  • Fundamental
  • Price
  • TBPH $14.58
  • CCNE $24.33
  • Analyst Decision
  • TBPH Strong Buy
  • CCNE Hold
  • Analyst Count
  • TBPH 4
  • CCNE 1
  • Target Price
  • TBPH $23.00
  • CCNE $29.00
  • AVG Volume (30 Days)
  • TBPH 367.5K
  • CCNE 130.2K
  • Earning Date
  • TBPH 11-11-2025
  • CCNE 10-20-2025
  • Dividend Yield
  • TBPH N/A
  • CCNE 2.96%
  • EPS Growth
  • TBPH N/A
  • CCNE 2.16
  • EPS
  • TBPH 0.26
  • CCNE 2.38
  • Revenue
  • TBPH $77,205,000.00
  • CCNE $224,762,000.00
  • Revenue This Year
  • TBPH $79.82
  • CCNE $17.68
  • Revenue Next Year
  • TBPH N/A
  • CCNE $30.32
  • P/E Ratio
  • TBPH $56.32
  • CCNE $10.23
  • Revenue Growth
  • TBPH 24.49
  • CCNE 4.79
  • 52 Week Low
  • TBPH $7.88
  • CCNE $19.32
  • 52 Week High
  • TBPH $15.15
  • CCNE $29.29
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 60.51
  • CCNE 41.97
  • Support Level
  • TBPH $14.00
  • CCNE $23.49
  • Resistance Level
  • TBPH $14.87
  • CCNE $25.83
  • Average True Range (ATR)
  • TBPH 0.50
  • CCNE 0.74
  • MACD
  • TBPH -0.02
  • CCNE -0.22
  • Stochastic Oscillator
  • TBPH 62.00
  • CCNE 26.33

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About CCNE CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. It derives revenue through the operations as a full-service bank engaging in a full range of banking activities and services, including trust and wealth management services, for individual, business, governmental, and institutional customers. The company branch are located in Pennsylvania, Ohio, New York and Virginia.

Share on Social Networks: